Glass maker Corning will receive $204 million from the U.S. government to boost the manufacturing capacity of vials that will be used to store coronavirus vaccines and treatments.
A federal appeals court revived nationwide litigation accusing Roche Holding AG’s Genentech unit of failing to ensure that vials of the comapny’s Herceptin breast cancer drug contained the labeled amount of the active ingredient, and that the labels misstated the drug’s concentration and volume.
U.S. drugmaker Pfizer Inc. signed a long-term agreement with glass maker Corning Inc. to procure vials for storing drugs.
